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Objectives. Our aim was to determine mechanisms underlying
abnormalities of right ventricular (RV) diastolic function seen in
heart failure.
Background. It is not clear whether these right-sided abnor-
malities are due to primary RV disease or are secondary to
restrictive physiology on the left side of the heart. The latter
regresses with angiotensin-converting enzyme inhibition (ACE-I).
Methods. Transthoracic echo-Doppler measurements of left-
and right-ventricular function in 17 patients with systolic left
ventricular (LV) disease and restrictive filling before and 3 weeks
after the institution of ACE-I were compared with those in 21
controls.
Results. Before ACE-I, LV filling was restrictive, with isovolu-
mic relaxation time short and transmitral E wave acceleration
and deceleration rates increased (p < 0.001). Right ventricular
long axis amplitude and rates of change were all reduced (p <
0.001), the onset of transtricuspid Doppler was delayed by 160 ms
after the pulmonary second sound versus 40 ms in normals (p <
0.001) and overall RV filling time reduced to 59% of total diastole.
Right ventricular relaxation was very incoordinate and peak E
wave velocity was reduced. Peak RV to right atrial (RA) pressure
drop, estimated from tricuspid regurgitation, was 45 6 6 mm Hg,
and peak pulmonary stroke distance was 40% lower than normal
(p < 0.001). With ACE-I, LV isovolumic relaxation time length-
ened, E wave acceleration and deceleration rates decreased and
RV to RA pressure drop fell to 30 6 5 mm Hg (p < 0.001) versus
pre-ACE-I. Right ventricular long axis dynamics did not change,
but tricuspid flow started 85 ms earlier to occupy 85% of total
diastole; E wave amplitude increased but acceleration and decel-
eration rates were unaltered. Values of long axis systolic and
diastolic measurements did not change. Peak pulmonary artery
velocity increased (p < 0.01).
Conclusions. Abnormalities of RV filling in patients with heart
failure normalize with ACE-I as restrictive filling regresses on the
left. This was not due to altered right ventricular relaxation or to
a fall in pulmonary artery pressure or tricuspid pressure gradient,
but appears to reflect direct ventricular interaction during early
diastole.
(J Am Coll Cardiol 1998;32:1187–93)
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Right atrial (RA) pressure is often raised in patients with
severe left ventricular (LV) disease, giving rise to the clinical
picture of congestive heart failure. In some cases, this may
reflect the presence of significant functional tricuspid regurgi-
tation, but more frequently it is due to high right ventricular
(RV) diastolic pressures. It is likely to be particularly promi-
nent when LV filling is restrictive (1). Previous studies in
patients with dilated cardiomyopathy have demonstrated ab-
normalities in RV filling that may be depressed during early
diastole and associated with striking incoordination when
correlated with RV wall motion (2,3). It remains unclear
whether these changes represent the effects of previous dia-
stolic RV disease, abnormal loading due to elevated left atrial
and thus pulmonary artery pressure, or some other mecha-
nism. It was the purpose of the present study to investigate this
question by studying interrelations between diastolic events on
the right and left sides of the heart in a group of patients with
severe LV disease, and to observe how these relations were
modified by treatment with angiotensin-converting enzyme
inhibition (ACE-I).
Methods
We studied 17 consecutive patients (age 60 6 10 years) who
conformed to the following criteria: 1) A diagnosis of heart
failure requiring treatment with ACE-I on purely clinical
grounds. 2) Evidence of LV systolic disease, with an end
diastolic dimension greater than 5.8 cm, the upper 95%
confidence interval (CI) of normal, and a shortening fraction
less than 20%. 3) A restrictive filling pattern as assessed by
pulsed echo-Doppler with an E/A ratio .1 and an E wave
deceleration time ,120 ms. 4) Satisfactory echo-Doppler
records from both sides of the heart. No patient had uncor-
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rected structural valve disease, pericardial disease or pulmo-
nary disease, and all were in sinus rhythm. Mild functional
mitral regurgitation was noted in 13 patients. No patient had
significant wall motion abnormality. The underlying cardiac
disease was coronary artery disease in eight patients, idiopathic
dilated cardiomyopathy in three patients, aortic valve replace-
ment in two patients, hypertension in two patients, sarcoidosis
in one patient (with no evidence of cor pulmonale) and in the
remaining patient it was unknown. The ACE-I prescribed and
its dose were determined by the referring physician; captopril
was given to eight patients, enalapril to four patients and
lisinopril to five patients. All patients were studied by echocar-
diography before and 3 weeks after starting treatment. Be-
tween the two echocardiographic studies other drugs were not
altered.
Twenty-one normal subjects, age 58 years (SD 11 years),
served as controls. They were studied by the same operators
and over the same time period as the study patients. None had
a history of shortness of breath, hypertension, valvular or
ischemic disease or pulmonary disease.
All patients were studied at rest. We obtained cross sec-
tional two-dimensional (Andover, Massachusetts) guided M
modes and Doppler velocities using a Hewlett Packard Sonos
1500 system with a 2.5 MHz transducer. With the patient lying
in the left semilateral position, M modes of the LV minor axis
were recorded from the parasternal long axis view with the
cursor at the tips of mitral valve leaflets. Long axis M-mode
recordings of RV free wall were obtained with the cursor
positioned at the tricuspid valve annulus (2). All records were
made during quiet expiration. Transmitral and transtricuspid
Doppler flow velocities were obtained using the same echocar-
diograph within 5 min of one another with the sample volume
at the tips of mitral and tricuspid valve leaflets in the apical
four-chamber view. Aortic and pulmonary outflow tract veloc-
ities were recorded with the pulsed-Doppler sample volume at
the valve tips from the parasternal short axis view and apical
four-chamber view, respectively. Continuous wave Doppler
traces of mitral and tricuspid regurgitation were recorded
using a Doptek system (Colchester, UK), with a 2.5 MHz
nonimaging transducer. The apexcardiogram was recorded
using Cambridge equipment (time constant 4 s). An electro-
cardiogram and phonocardiogram were recorded superim-
posed on all M-mode, Doppler and pulse traces which were
photographically recorded at a paper speed of 100 mm/s.
M-mode traces were later digitized off line using a dedicated
computer program (4).
Measurements. End diastolic LV dimensions were taken at
the onset of the q wave of the electrocardiogram (ECG), and
end systolic dimensions were taken at the first high-frequency
component of the aortic component of the second heart sound
(A2) of the phonocardiogram. Left ventricular fractional
shortening was estimated as the percentage fall in dimension
during ejection with respect to end diastolic dimension. Iso-
volumic relaxation time was measured from the mitral valve
echogram as the time interval between A2 and the onset of
mitral cusp separation. Right ventricular, long axis total excur-
sion was measured from the innermost point (at end systole) to
the outermost point (at end diastole). The A wave was taken as
the extent of additional long axis motion between the end of
the P wave of the ECG and the onset of the succeeding systole.
Incoordinate relaxation was measured as the amplitude of
abnormal movement after A2 or P2 (the pulmonary second
sound), during early diastole, before the onset of mitral or
tricuspid flow motion, respectively, towards the ventricular
apex being expressed as positive and toward the atria as
negative. The identities of A2 and P2, the aortic and pulmo-
nary components of the second heart sound, were routinely
checked against the corresponding valve closure artifact on the
aortic and pulmonary Doppler flow velocity traces. From the
digitized traces, peak LV minor axis and RV, long axis
shortening (in systole) and lengthening (in diastole) were
measured as well as the time interval between the q wave and
peak shortening rate and the second heart sound, A2 or P2,
and peak lengthening rate.
From the transmitral and transtricuspid pulsed-Doppler
traces, peak early and late diastolic filling velocities were
measured and the E/A ratio calculated. Total LV and RV
filling times were measured as the total duration of transmitral
and transtricuspid flow, respectively, and the ratio of each to
total diastolic time calculated. Total diastolic time itself was
measured as the period between the onset of P2 and the onset
of the q wave of the ECG of the succeeding beat. Mitral and
tricuspid E-wave acceleration times were measured from onset
to peak velocity, and mean acceleration rates as peak velocity
divided by corresponding acceleration time. Deceleration
times and rates were measured in the same way on both sides
of the heart, the former being derived by extrapolation if the A
wave was partially superimposed on the descending limb of the
E wave. A wave velocity was measured with respect to baseline.
Pressure gradients in mm Hgzcm21 were calculated as 0.075 3
acceleration rate in mzs22. Right ventricular to RA systolic
pressure drop was measured from the peak tricuspid regurgi-
tation velocity as assessed by continuous wave Doppler and
presented in mm Hg, using the simplified Bernoulli equation.
Peak LV and RV outflow tract velocities were measured from
the pulsed-Doppler trace. Aortic and pulmonary total ejection
times were measured from the same trace, and stroke distance
was derived. The percentage of end diastolic A wave amplitude
to total pressure amplitude was measured from the apexcar-
diogram.
Statistics. Values are expressed as mean 6 SD. Patients’
values before treatment with ACE-I were compared with
Abbreviations and Acronyms
ACE-I 5 angiotensin converting enzyme inhibition
LA 5 left atrial
LV 5 left ventricular
P2 5 pulmonary component of the second sound
RA 5 right atrial
RV 5 right ventricular
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controls using unpaired Student t test. Patient data before and
after treatment were compared using a paired t test. In view of
multiple t tests, a Bonferroni correction was implemented and
the statistical significance was taken to apply when p value was
less than 0.017.
Results
Before ACE-I (Tables 1 to 3). Left ventricle. By definition,
the LV cavity was dilated. Mean end diastolic dimension
proved to be 7.1 6 1.2 cm and fractional shortening was low,
14% 6 2.5%. Left ventricular isovolumic relaxation time was
short, being reduced to 25% normal value (p , 0.001 vs.
normal). Transmitral Doppler showed increased acceleration
and deceleration rates, particularly the latter by a factor of
nearly 3 (p , 0.001 vs. normal). Total LV filling time was
approximately 100 ms shorter than that in normals (p , 0.01),
as was total diastolic time, so their ratio remained within the
normal range. Peak aortic velocity, total ejection time and
aortic stroke distance were all normal. Pressure A wave on the
apexcardiogram was raised to almost 50% of the total displace-
ment (p , 0.001 vs. normal) (Table 1).
Right ventricle. Total systolic excursion of RV long axis was
40% lower than normal, and peak shortening rate was 25%
lower (p , 0.001 for both vs. normal). The time interval
between the q wave of the ECG and the timing of peak
shortening rate was not different between patients and con-
trols. The degree of RV, long axis lengthening between P2 and
the onset of tricuspid flow was much greater in patients (p ,
0.01 vs. normal), particularly when expressed as a percentage
of total excursion. The peak rate of RV, long axis lengthening
was low in patients (p , 0.001 vs. normal), and the peak value
itself occurred early in respect to P2 (p , 0.001 vs. normal). A
wave amplitude was normal (Table 2).
Right-side Doppler (Fig. 1). The onset of transtricuspid flow
was strikingly delayed with respect to P2 by 160 ms compared
to only 40 ms in normals (p , 0.001). E-wave acceleration time
was shorter than normal by 25 ms (p , 0.001), and peak
E-wave velocity was reduced (p , 0.001), although mean
acceleration rate was within the normal range. On the other
Table 2. Right Ventricular and Septal Long Axis Function
Controls
(n 5 2)
Patients (n 5 17)
Pre ACE-I With ACE-I
Total excursion (cm) 2.6 6 0.3 1.6 6 0.5** 1.7 6 0.6§
Peak shortening rate
(cm/s) 10 6 2.0 7.3 6 2.5** 7.5 6 2.9‡
Dimension change during
IVRT (mm) 3 6 1 7 6 2* 3 6 1.2†
Peak lengthening rate
(cm/s) 10 6 2.5 6.3 6 2.3** 5.9 6 3.6‡
P2-peak lengthening (ms) 150 6 7 92 6 4** 100 6 6§
A wave amplitude (cm) 0.9 6 0.1 0.78 6 0.3 0.84 6 0.3
*p , 0.01; **p , 0.001 patients before ACE-I vs. controls (unpaired t test);
†p , 0.01 patients with ACE-I vs. before ACE-I (paired t test); ‡p , 0.01; §p ,
0.001 patients after ACE-I vs. controls (unpaired t test). ACE-I 5 angiotensin-
converting enzyme inhibition; IVRT 5 isovolumic relaxation time.




Patients (n 5 17)
Pre-ACE-I With ACE-I
R-R interval (ms) 940 6 200 715 6 145 790 6 180
Isovolumic relaxation time (ms) 60 6 10 11 6 17** 82 6 40†
Mitral Doppler
A2-onset of mitral flow (ms) 80 6 15 60 6 17** 120 6 30†§
Peak E wave velocity (cm/s) 70 6 10 86 6 17 47 6 20†§
E acceleration time (ms) 75 6 10 66 6 13 79 6 15
E acceleration rate (mzs22) 10 6 2.0 13.5 6 4.0** 6.7 6 3.0†§
Early diastolic pressure
gradient (mm Hg/cm) 0.75 6 0.1 1.01 6 0.1** 0.5 6 0.1†§
E deceleration time (ms) 160 6 20 73 6 19** 120 6 30†§
E deceleration rate (mzs22) 4.6 6 1.6 12 6 4** 4.7 6 2†
Peak A wave velocity (cm/s) 50 6 10 32 6 26* 75 6 20†§
E/A ratio 1.4 6 0.4 2.7 6 1.8* 0.8 6 0.9†‡
Total filling time (ms) 380 6 125 286 6 85* 320 6 100
Total diastolic time (ms) 430 6 20 345 6 100** 410 6 150
Filling/diastolic time (%) 88 6 10 83 6 12 79 6 11
Apexcardiogram
A wave/total pressure (%) 15 6 5 48 6 20** 16 6 7†
Peak aortic velocity (cm/s) 110 6 20 100 6 40 90 6 35
Total ejection time (ms) 240 6 20 238 6 29 240 6 25
Aortic stroke distance (cmzs22) 12.2 6 2.0 12.3 6 7.0 11.1 6 4
*p , 0.01; **p , 0.001 patients before ACE-I vs. controls (unpaired t test); †p , 0.001 patients with ACE-I vs. before
ACE-I (paired t test); ‡p , 0.01; §p , 0.001 patients after ACE-I vs. controls (unpaired t test). ACE-I 5
angiotensin-converting enzyme inhibition.
1189JACC Vol. 32, No. 5 HENEIN ET AL.
November 1, 1998:1187–93 ACE-I REVERTS RV FILLING IN RESTRICTIVE LV DISEASE
hand, E wave deceleration time was 50% less than normal, so
that mean deceleration rate was higher (p , 0.01). Peak A
wave velocity was 19 cm/s higher than normal (p , 0.001).
Thus, E/A ratio was only one fourth the normal value in
patients (p , 0.001). The delayed onset of flow caused total
RV filling time to be less than 50% that in normals whether
expressed in absolute terms or as a percentage of total diastole
(p , 0.001 each). The mean systolic pressure drop between the
right ventricle and the right atrium, as assessed from the
tricuspid regurgitation, was 46 mm Hg. Peak pulmonary artery
ejection time and systolic stroke distance were both lower than
normal (p , 0.001) (Table 3).
With ACE-I (Tables 1 to 3). Left ventricle. With the start of
ACE-I, LV cavity dimensions both fell but fractional shorten-
ing did not change. The delay in the onset of transmitral flow
with respect to A2 increased by 120 ms (p , 0.001). E wave
deceleration time increased and both mean acceleration and
deceleration rates dropped strikingly, as did early diastolic
pressure gradient compared with pre-ACE-I values (p ,
0.001). E-wave velocity fell and that of the A wave increased so
that E/A ratio fell to one third of control value. Total trans-
mitral flow period did not change, although diastole itself
increased by 60 ms, but the ratio between the two showed no
consistent change after ACE-I (Table 1).
On the right side (Fig. 1). The RV–RA peak systolic pres-
sure drop fell by 15 mm Hg, although all aspects of systolic long
axis function (total excursion, peak shortening rate and time
interval between q wave and peak shortening rate) were
unaltered (Tables 2 and 3). However, there were major
changes in transtricuspid flow velocities. The onset of the E
wave occurred 85 ms earlier with respect to P2, peak E wave
velocity more than doubled; deceleration time was prolonged
but neither mean acceleration rate nor deceleration rate
changed. Peak A wave velocity was also unchanged, so that
E/A ratio doubled. The shortening of the time interval P2 to
the onset of tricuspid flow meant that the extent of long axis
lengthening before the onset of flow fell, but peak long axis
lengthening rate itself was unchanged, as was the timing of the
peak value that remained earlier than normal with respect to
P2. Total tricuspid flow period more than doubled, although
diastolic time itself increased only by 20% so that there was a
marked increase in the ratio of flow time to total diastolic time
(p , 0.001). Peak pulmonary artery velocity also increased
(Table 3).
Discussion
Findings. Our patients were selected to have systolic LV
disease with a restrictive filling pattern. The left-sided changes
with ACE-I were explicable on the basis of a reduction in left
atrial (LA) pressure rather than any direct cardiac effect (5).
On the right side of the heart, the systolic pressure drop across
the tricuspid valve under control conditions was 46 mm Hg,
compatible with raised LA and pulmonary artery pressures.
The amplitude of RV, long axis motion was reduced, along
with both shortening and lengthening rates. Peak lengthening
rate occurred early with respect to P2, but the extent of change
in long axis with RA systole was normal. In spite of this, the
major disturbances to the pattern of transtricuspid flow previ-
ously described were present (3). Peak E wave velocity was
Table 3. Right Ventricular Inflow and Outflow Values
Control
(n 5 21)
Patients (n 5 17)
Pre-ACE-I With ACE-I
Tricuspid Doppler
P2-onset of flow (ms) 40 6 15 160 6 90** 75 6 55§\
Peak E wave velocity (cm/s) 40 6 15 10 6 14** 29 6 10§\
E acceleration time (ms) 80 6 23 54 6 11** 83 6 25
E acceleration rate (m/s22) 5 6 1 5.6 6 2.7 4 6 1\
Early diastolic pressure gradient (mm Hg/cm) 0.38 6 0.08 0.4 6 0.1 0.28 6 0.1‡\
E deceleration time (ms) 140 6 20 77 6 14** 93 6 31§¶
E deceleration rate (mzs22) 3.0 6 0.8 3.9 6 1.5* 3.6 6 1.0
Peak A wave velocity (cm/s) 20 6 10 39 6 20* 30 6 13
E/A ratio 1.9 6 0.4 0.47 6 0.8** 1.2 6 0.7§\
Total filling time (ms) 385 6 150 170 6 60** 320 6 100§
Total diastolic time (ms) 460 6 20 335 6 90** 410 6 50‡\
Filling/diastolic time (%) 95 6 8 50 6 12** 80 6 13§\
PV–RA pressure drop (mm Hg) — 45 6 6 30 6 5§
P2-end of TR (ms) — 43 6 5 29 6 2.5†
Peak pulmonary velocity (cm/s) 75 6 10 63 6 20 70 6 20†
Pulmonary ejection time (ms) 325 6 25 235 6 31** 240 6 25¶
Pulmonary stroke distance (cmzs22) 11.8 6 2.0 7 6 2.4** 9.3 6 2.9\
*p , 0.01; **p , 0.001 patients before ACE-I vs. controls (unpaired t test); †p , 0.01; ‡p , 0.005; §p , 0.001 patients
with ACE-I vs. before ACE-I (paired t test); \p , 0.01; ¶p , 0.001 patients after ACE-I vs. controls (unpaired t test).
ACE-I 5 angiotensin-converting enzyme inhibition; RV–RA 5 right ventricular–right atrial; TR 5 tricuspid regurgita-
tion.
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reduced, although mean acceleration and deceleration rates
were both normal. The onset of detectable flow across the
valve in early diastole was strikingly delayed by a mean value of
160 ms; during this period, 44% of total long axis lengthening
had occurred, implying incoordinate filling (2). As a result of
this delay, the total period of transtricuspid flow was reduced
to 170 ms, representing only 50% of the total diastolic period,
compared with a value of 83% of the left. A wave amplitude
was somewhat increased so that E/A ratio was low. The nature
of the right-side abnormalities thus differed fundamentally
from those on the left.
Right-side events also changed strikingly with ACE-I. As
would be expected from a fall in LA pressure, the systolic pressure
drop across the tricuspid valve fell by 15 mm Hg. In spite of this,
the dynamics of right-side long axis did not change. The main
changes were in the pattern of transtricuspid flow. The onset
became earlier, and its overall duration increased by over 100 ms,
so that it came to occupy 80% of the total diastolic time. E wave
amplitude increased, but neither mean acceleration rate nor local
pressure gradient changed. A wave amplitude was unaltered, but
E/A ratio increased. ACE-I thus led to a normalization of RV
filling, the changes being largely in the opposite direction to those
occurring on the left side.
Mechanisms. There are a number of possible mechanisms
for these right-side abnormalities. In any population of pa-
tients with LV disease, additional involvement of the right
ventricle by the same or a related disease process will be
present to a variable extent in individual patients (6). In
addition, the right heart is subject to abnormal loading condi-
tions caused by elevation of the LA pressure transmitted via
the pulmonary artery and also of RA pressure (7). A low stroke
volume may be imposed on it by severe left-side disease.
Finally, the right side is subject to ventricular interaction
mediated either via the pericardium or the septum (8–10).
Figure 1. A composite of the transmitral and
transtricuspid pulsed-Doppler flow and RV,
long axis from a patient before ACE-I (left) and
with ACE-I (right). Note the restrictive mitral
filling pattern before treatment and its regres-
sion with ACE-I. There is no significant change
in RV long axis motion with treatment, but
tricuspid flow starts earlier and the extent of
incoordinate RV ring motion falls. Continuous
vertical lines represent A2 and dotted vertical
lines represent the onset of tricuspid flow.
Calibration: velocity 20 cmzs21; depth 1 cm;
time 40 and 200 ms, respectively.
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Some of these possible mechanisms were seen in the present
series of patients. The peak systolic pressure drop supporting
tricuspid regurgitation was increased under control conditions
and fell with treatment. The reduced extent of RV, long axis
shortening is compatible with additional RV disease rather
than abnormal loading because neither its extent nor its
velocity was affected as RV to pulmonary artery pressure
difference fell.
The most striking abnormality under control conditions was
in the timing of tricuspid flow so that its onset was more than
100 ms later than normal, leading to marked asynchrony when
compared to early diastolic lengthening of the RV long axis.
Neither the timing nor the velocity of this lengthening was
affected by ACE-I, making a primary disturbance of RV
relaxation a very unlikely cause. As the timing of flow reverted
toward normal, the extent of asynchrony regressed. Once the
transtricuspid E wave pressure gradient developed, it was
normal under control conditions, and was slightly affected by
treatment. A change in the magnitude of the pressure gradient
therefore was not the cause of abnormal flow. An increase in
peak tricuspid regurgitation pressure is always accompanied by
prolongation of overall RV systole by approximately 10 ms for
each 10 mm Hg peak pressure increase (11). This effect was
demonstrated with ACE-I in our patients with a fall in the
interval from P2 to the end of regurgitation by 15 ms, but it was
much too small to explain the change in the timing of flow, thus
excluding another possible mechanism. There was a striking
return of the timing of transtricuspid flow towards normal,
however, as the restrictive filling pattern on the left side of the
heart resolved by treatment. This was apparent not only from
group values but from those in individual patients (Fig. 2). It
occurred as the left-side pressure gradient fell from supranor-
mal values before treatment to abnormally low volumes after-
ward. It seems, therefore, that the likeliest explanation for our
findings is an early diastolic ventricular interaction and we
hypothesize that high left-side pressures may delay the onset of
a forward pressure gradient and hence atrioventricular dia-
stolic flow on the right side.
Limitations. The most significant limitation is that the
findings apply only to patients taking diuretics in clinically
appropriate doses, which will certainly have modified right-side
artrioventricular pressure gradients. Indeed, this is a major
indication for their use. Unfortunately, it is effectively impos-
sible in the West to recruit patients with heart failure who have
not already been treated with diuretics (12). We did not
attempt to measure pressure gradients directly. Unlike simple
pressures, measuring pressure gradients, which have the phys-
ical dimensions of mm Hgzcm21, requires at least two high-
Figure 2. A plot in individual patients of transmitral E wave acceler-
ation rate versus the time interval between P2 and the onset of
tricuspid flow. Note the consistent fall of the former coinciding with
shortening in the latter in all patients. Closed circles 5 patients under
control condition; open circles 5 after treatment.
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fidelity catheter transducers across the valve with their sensi-
tive elements a certain distance apart. Such records are
technically difficult to make and are seldom undertaken.
Instead, we preferred to rely on the relationship between force
and acceleration as defined by Newton’s Second Law of
Motion to calculate the pressure gradient from the more easily
measured velocity. Theoretically, Doppler signals may be
delayed with respect to echocardiographic data resulting from
fast Fourier transform algorithm. We have previously shown
them to be small (13). Their presence would not affect
estimates of overall filling time nor relative changes associated
with treatment. As in previous studies, partial merging of E
and A waves means that deceleration time has to be measured
by extrapolation, and apparent a wave amplitude may be
sensitive to heart rate, although it did not significantly change
with ACE-I. When investigating ventricular interactions, mea-
surements should ideally be made on both sides of the heart
simultaneously, particularly when the timing of events is being
correlated. Unfortunately, this is not possible with standard
echocardiographic equipment. Finally, with the relatively small
number of patients studied, it was not possible to investigate
any possible correlation of these disturbances with underlying
diagnoses.
Conclusions. Our results indicate that a restrictive filling
pattern of the left side of the heart is often associated with
striking delay in the onset of transtricuspid flow on the right
side, with secondary incoordination and reduction in peak
E-wave velocity. Right ventricular disease or a primary distur-
bance of RV relaxation are unlikely causes. Their regression
along with that of the restrictive filling pattern on the left side
with ACE-I strongly suggests that right-side filling abnormali-
ties may be directly related to high early diastolic pressures in
the left ventricle. The time relations between the two within
the cardiac cycle seem to indicate a direct ventricular interac-
tion rather than the simple effect of secondary pulmonary
hypertension. We suggest that the implications of these right-
side abnormalities merit further study, particularly with respect
to their relation to fluid retention, exercise tolerance and heart
rate variability. Their prompt regression with ACE-I provides
further evidence of the comprehensive effects of these remark-
able drugs.
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